Brief: Aurinia Pharmaceuticals To Report Q3 Results, Provide Update On Recent Business Progress On November 4
03/11/2025 11:12
Nov 3 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O: AURINIA PHARMACEUTICALS TO REPORT FINANCIAL RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2025 AND PROVIDE UPDATE ON RECENT BUSINESS PROGRESS ON NOVEMBER 4, 2025 Source text: ID:nBw298wYka Further company coverage: AUPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death